Ceryvyn Therapeutics Ltd. (CYVNY)
0.026
-0.01
(-25.71%)
USD |
OTCM |
Oct 07, 16:00
Ceryvyn Therapeutics Market Cap : 4.446M for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 4.446M |
| October 06, 2026 | 5.985M |
| October 05, 2026 | 4.001M |
| October 02, 2026 | 4.001M |
| October 01, 2026 | 4.001M |
| September 30, 2026 | 4.001M |
| September 29, 2026 | 4.001M |
| September 28, 2026 | 4.001M |
| September 25, 2026 | 4.001M |
| September 24, 2026 | 4.001M |
| September 23, 2026 | 3.933M |
| September 22, 2026 | 3.933M |
| September 21, 2026 | 6.489M |
| September 18, 2026 | 3.967M |
| September 17, 2026 | 3.967M |
| September 16, 2026 | 3.933M |
| September 15, 2026 | 3.933M |
| September 14, 2026 | 3.933M |
| September 11, 2026 | 3.933M |
| September 10, 2026 | 3.933M |
| September 09, 2026 | 3.779M |
| September 08, 2026 | 3.779M |
| September 04, 2026 | 5.814M |
| September 03, 2026 | 3.967M |
| September 02, 2026 | 3.967M |
| Date | Value |
|---|---|
| September 01, 2026 | 3.420M |
| August 31, 2026 | 3.967M |
| August 28, 2026 | 3.967M |
| August 27, 2026 | 3.967M |
| August 26, 2026 | 3.967M |
| August 25, 2026 | 3.967M |
| August 24, 2026 | 3.762M |
| August 21, 2026 | 3.762M |
| August 20, 2026 | 3.762M |
| August 19, 2026 | 3.762M |
| August 18, 2026 | 3.762M |
| August 17, 2026 | 3.762M |
| August 14, 2026 | 3.762M |
| August 13, 2026 | 3.762M |
| August 12, 2026 | 5.130M |
| August 11, 2026 | 5.130M |
| August 10, 2026 | 4.788M |
| August 07, 2026 | 3.762M |
| August 06, 2026 | 3.779M |
| August 05, 2026 | 3.762M |
| August 04, 2026 | 4.668M |
| August 03, 2026 | 4.668M |
| July 31, 2026 | 4.463M |
| July 30, 2026 | 4.446M |
| July 29, 2026 | 4.446M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 28.48M |
| CSL Ltd. | 60.36B |
| Propanc Biopharma, Inc. | 1.527M |
| Mesoblast Ltd. | 1.752B |
| Actinogen Medical Ltd. | 198.16M |
Market Cap Related Metrics
| PE Ratio | 0.02 |
| PS Ratio | 6267.60 |
| Price | 0.026 |
| Earnings Yield | 5.00K% |
| Normalized PE Ratio | 0.0825 |